![]() |
市場調查報告書
商品編碼
1884050
處方太陽眼鏡市場規模、佔有率、成長及全球產業分析:按類型、應用和地區劃分的洞察與預測(2024-2032 年)Prescription Sunglasses Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2024-2032 |
||||||
隨著越來越多的消費者尋求兼具視力矯正和紫外線防護功能的眼鏡,全球處方太陽眼鏡市場持續擴張。根據最新的市場評估,該市場在 2024 年的價值為 66.7 億美元,2025 年將成長至 69.5 億美元,預計到 2032 年將達到 94.4 億美元,預測期內複合年增長率 (CAGR) 為 4.5%。處方太陽眼鏡已從單純的視力輔助工具發展成為生活方式和時尚產品,成為屈光不正、數位眼睛疲勞和強光照射人群的必備之選。
2024 年,歐洲以 38.98% 的市佔率引領全球市場。這得益於強大的眼鏡文化、奢侈時尚品牌以及設計師處方太陽眼鏡日益增長的受歡迎程度。義大利、德國和法國等主要製造商和分銷商的存在進一步鞏固了該地區的領先地位。
市場動態
市場驅動因素
眼部疾病的上升趨勢
近視、老花眼和其他屈光不正的發病率不斷上升是推動全球處方太陽眼鏡需求的主要因素。根據國際近視研究所 (IMI) 預測,到 2025 年,全球 30% 的人口將患有近視,到 2050 年,這一比例將達到約 50%。這種日益嚴重的負擔正在推動人們對矯正眼鏡的需求,尤其是在戶外強光環境下工作的人。
此外,各大公司正積極拓展中國、印度和巴西等新興市場,這些市場屈光不正的人口基數正快速成長。這種策略轉變正在增加產品供應,並支持強勁的市場成長。
市場限制因子
保險覆蓋範圍有限
在許多已開發國家和發展中國家,處方太陽眼鏡不在保險覆蓋範圍內,這構成了購買障礙。例如,美國醫療保險(Medicare)不涵蓋眼鏡產品的費用,僅在白內障手術後少數情況下才會報銷。同樣,印度的保險公司也不報銷眼鏡或太陽眼鏡的費用。這迫使用戶自費,限制了眼鏡的普及。
市場機會
近視盛行率上升與技術創新
由於近視盛行率上升、可支配所得增加以及眼鏡零售網絡不斷擴張,新興經濟體蘊藏著巨大的成長機會。各公司正迅速從傳統分銷模式轉向全通路模式,同時提供線上線下購買通路。 2024年7月,Lenskart投資2,000萬美元用於全通路擴張,以加強處方太陽眼鏡的分銷,從而為產品滲透開闢新的機會。
人工智慧與鏡片驗配、虛擬試戴工具和精準光學測量技術的融合,正在推動眼鏡產業的進一步成長,尤其是在數位化優先的市場。
市場挑戰
產品成本高
由於定製鏡片、優質材料和先進鍍膜,處方太陽眼鏡比普通眼鏡價格更高。美國、歐洲和中國之間的關稅和進口限制進一步推高了價格。此外,某些國家嚴格的進出口法規也為製造商設置了障礙,影響全球供應鏈和零售價格。
市場趨勢
時尚與功能的融合
處方太陽眼鏡正在演變為整合藍牙、擴增實境功能、健身應用和免持通訊工具的智慧型穿戴裝置。 2025年5月,Meta宣佈在印度推出Ray-Ban Meta智慧眼鏡,體現了科技與時尚的融合。
採用生物醋酸纖維、竹子和再生塑膠製成的可持續眼鏡正受到千禧世代和Z世代消費者的廣泛青睞,重塑著長期的市場趨勢。
細分市場亮點
按鏡框款式
2024年,矩形鏡框憑藉著適應性和在各年齡層的普及度,佔據市場主導地位。方形鏡框則位居第二,主要得益於強勁的時尚潮流和流行文化的影響。
按鏡片類型
2024年,非偏光鏡片因其在陽光充足地區的受歡迎程度而佔據最大市場佔有率。同時,偏光鏡片也因其出色的戶外可視性而保持強勁增長。
按應用
近視鏡鏡片因其高普及率,在2024年佔據市場主導地位。截至2025年1月,據報道,超過40%的美國成年人患有近視。
依通路劃分
2024年,零售商店佔據市場主導地位,這主要得益於收購,例如Fielmann AG在2024年收購了Shopko Optical。由於電子商務的快速發展,預計在線商店的增長率最高。
歐洲
2024年,歐洲以26億美元的市場規模領先,這主要得益於強勁的時尚需求和大型光學設備分銷商的存在。
北美
北美市場排名第二,這得益於較高的眼部健康意識和智慧眼鏡的早期普及。 Warby Parker在2023年持續擴張其零售網絡,進一步鞏固了其市場滲透率。
亞太地區
由於中產階級收入的成長和老花眼患者人數的增加,中國和印度等國家正經歷著強勁的市場成長。 2021年,光是中國就有超過4億人患有老花眼。
The global prescription sunglasses market continues to expand as consumers increasingly seek eyewear that combines both vision correction and UV protection. According to the latest market assessment, the market was valued at USD 6.67 billion in 2024, is expected to rise to USD 6.95 billion in 2025, and is projected to reach USD 9.44 billion by 2032, exhibiting a CAGR of 4.5% during the forecast period. Prescription sunglasses have evolved from simple optical aids into lifestyle and fashion products, becoming essential for individuals dealing with refractive errors, digital eye strain, and intense sunlight exposure.
In 2024, Europe dominated the global market with a 38.98% share, supported by strong eyewear culture, premium fashion brands, and rising adoption of designer prescription sunglasses. The region's leadership is further amplified by the presence of major manufacturers and distributors across Italy, Germany, and France.
Market Dynamics
Market Drivers
Rising Prevalence of Ocular Disorders
The growing incidence of myopia, presbyopia, and other refractive disorders is a major factor driving global demand for prescription sunglasses. According to the International Myopia Institute (IMI), 30% of the global population was myopic in 2025, and by 2050, nearly 50% is expected to be affected. This escalating burden is increasing the need for corrective eyewear, especially for individuals exposed to bright outdoor environments.
Furthermore, major players are actively entering emerging markets such as China, India, and Brazil, where the population base with refractive errors is rapidly expanding. This strategic shift enhances product accessibility and supports strong market growth.
Market Restraints
Limited Reimbursement Policies
In several developed and developing countries, prescription sunglasses lack insurance coverage, limiting affordability. For instance, U.S. Medicare does not cover eyewear products except for limited cases following cataract surgery. Similarly, insurance providers in India exclude spectacle and sunglasses reimbursement. This forces users to bear out-of-pocket expenses, restricting wider adoption.
Market Opportunities
Growing Myopia Cases & Technological Advancements
Emerging economies present massive growth opportunities due to rising myopia cases, increasing disposable incomes, and expanding optical retail networks. Companies are rapidly shifting from conventional distribution to omnichannel models, providing both in-store and online accessibility. In July 2024, Lenskart invested USD 20 million into omnichannel expansion to enhance prescription sunglasses distribution, opening new opportunities for product penetration.
The integration of AI for lens fitting, virtual try-on tools, and precise optical measurements is further enabling growth, especially in digital-first markets.
Market Challenges
High Product Costs
Prescription sunglasses cost more than regular eyewear due to custom lenses, premium materials, and advanced coatings. Tariffs and import restrictions between the U.S., Europe, and China further elevate prices. Additionally, stricter import/export rules in certain nations pose barriers for manufacturers, impacting global supply chains and retail pricing.
Market Trends
Fashion Meets Function
Prescription sunglasses have evolved into smart wearable devices, integrating Bluetooth, AR features, fitness applications, and hands-free communication tools. In May 2025, Meta announced the introduction of Ray-Ban Meta smart glasses in India, showcasing the blend of technology and fashion.
Sustainable eyewear, made using bio-acetate, bamboo, and recycled plastics, is gaining significant traction among millennials and Gen Z consumers, reshaping long-term market trends.
Segmentation Highlights
By Frame Style
The rectangle frame segment dominated in 2024 due to its adaptability across age groups and rising availability. Square frames accounted for the second-largest share, supported by strong fashion trends and pop culture influence.
By Lens Type
Non-polarized lenses held the largest share in 2024 due to widespread adoption in high-sunlight regions. The polarized segment remains strong due to superior outdoor clarity.
By Application
Myopia led the market in 2024, backed by high prevalence rates. More than 40% of U.S. adults were reported to be nearsighted in January 2025.
By Distribution Channel
Retail stores dominated in 2024, supported by acquisitions such as Fielmann AG's 2024 acquisition of Shopko Optical. Online stores are expected to grow at the highest rate due to rapid e-commerce expansion.
Europe
Europe led the market with USD 2.60 billion in 2024, driven by strong fashion demand and the presence of large optical distributors.
North America
The market ranked second, supported by high awareness of ocular health and early adoption of smart eyewear. Warby Parker's continued retail expansion in 2023 strengthened market penetration.
Asia Pacific
Countries like China and India are experiencing strong market growth due to rising middle-class incomes and increasing prevalence of presbyopia-China alone had 400 million+ presbyopic individuals in 2021.
Conclusion
With market values rising from USD 6.67 billion in 2024 to USD 6.95 billion in 2025 and projected to reach USD 9.44 billion by 2032, the global prescription sunglasses market is on a steady growth path. Increasing vision disorders, technological advancements, premium eyewear trends, and expanding online distribution will continue to shape the industry over the coming decade.
Segmentation By Frame Style
By Lens Type
By Application
By Distribution Channel
By Region